Prevalence of QT interval prolongation in patients admitted to cardiac care units and frequency of subsequent administration of QT interval-prolonging drugs: A prospective, observational study in a large urban academic medical center in the US

Drug Safety

Volumn 35, Issue 6, 2012, Pages 459-470

  Tisdale, James E ^a,b   Wroblewski, Heather A ^a   Overholser, Brian R ^a,b   Kingery, Joanna R ^c   Trujillo, Tate N ^c   Kovacs, Richard J ^b  

^a PURDUE UNIVERSITY   (United States)

^b INDIANA UNIVERSITY   (United States)

^c INDIANA UNIVERSITY HEALTH   (United States)

Author keywords

Acute heart failure; Amiodarone; Angioplasty; Atrial fibrillation; Azithromycin; Ciprofloxacin; Coronary artery disease; ECG; Erythromycin; Fluconazole; Heart arrest; Levofloxacin; Methadone; Moxifloxacin; Myocardial infarction; Procainamide; QT interval prolongation; Ranolazine; Sotalol; Torsades de pointes; Ziprasidone

Indexed keywords

AMIODARONE; AZITHROMYCIN; CIPROFLOXACIN; ERYTHROMYCIN; FLUCONAZOLE; HALOPERIDOL; LEVOFLOXACIN; METHADONE; MOXIFLOXACIN; PROCAINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RANOLAZINE; RISPERIDONE; SOTALOL; ZIPRASIDONE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY CARE UNIT; ELECTROCARDIOGRAM; FEMALE; HEART ARREST; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTPATIENT; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QT INTERVAL; QT PROLONGATION; TELEMETRY; TORSADE DES POINTES; UNITED STATES; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; AGED; AGED, 80 AND OVER; CARDIAC CARE FACILITIES; ELECTROCARDIOGRAPHY; FEMALE; GREAT LAKES REGION; HOSPITALIZATION; HUMANS; INTENSIVE CARE UNITS; LONG QT SYNDROME; MALE; MIDDLE AGED; PHARMACEUTICAL PREPARATIONS; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; TORSADES DE POINTES; UNITED STATES; URBAN POPULATION;

EID: 84861376254     PISSN: 01145916     EISSN: 11791942     Source Type: Journal    
DOI: 10.2165/11598160-000000000-00000     Document Type: Article

References (18)

1. Gupta A, Lawrence AT, Krishnan K, et al. Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes. Am Heart J 2007; 153 (6): 891-9 (Pubitemid 46809861)
2. Bauman JL, Bauernfeind RA, Hoff JV, et al. Torsade de pointes due to quinidine: observations in 31 patients. Am Heart J 1984; 107: 425-30 (Pubitemid 14167715)
3. Tisdale JE. Ventricular arrhythmias. In: Tisdale JE, Miller DA, editors. Drug-induced diseases: prevention, detection and management, 2nd ed. Bethesda (MD): American Society of Health-System Pharmacists, 2010: 485-515
4. Drew BJ, Ackerman MJ, Funk M, et al., on behalf of the American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology, the Council on Cardiovascular Nursing, and the American College of Cardiology Foundation. Prevention of torsade de pointes in hospital settings: a scientific statement fromthe American Heart Association and the American College of Cardiology Foundation. Circulation 2010; 121 (8): 1047-60
5. Bazett HC. An analysis of time relationships of the electrocardiogram. Heart 1920; 7: 353-70
6. Roden DM, Woosley RL, Primm RK. Incidence and clinical features of the quinidine-associated long QT syndrome: implications for patient care. Am Heart J 1986; 111 (6): 1088-93 (Pubitemid 16085013)
7. Woosley RL, Chen Y, Freiman JP, et al. Mechanism of the cardiotoxic actions of terfenadine. JAMA 1993; 269 (12): 1532-6 (Pubitemid 23086414)
8. De Bruin ML, Langendijk PN, Koopmans RP, et al. Inhospital cardiac arrest is associated with use of nonantiarrhythmic QTc-prolonging drugs. Br J Clin Pharmacol 2007; 63 (2): 216-23 (Pubitemid 46072108)
9. Surawicz B, Childers R, Deal BJ, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram, part III: intraventricular conduction disturbances: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Circulation 2009; 119 (10): e235-40
10. Lubart E, Segal R, Yearovoi A, et al. QT interval disturbances in hospitalized elderly patients. Isr Med Assoc J 2009; 11 (3): 147-50
11. Dumontet J,MalyukR,KiangG, et al. CorrectedQT intervals in newly admitted geriatric psychiatric patients: an examination of risk factors. Can J Psychiatry 2006; 51 (6): 371-6
12. Seftchick MW, Adler PH, Hsieh M, et al. The prevalence and factors associated with QTc prolongation among emergency department patients. Ann Emerg Med 2009; 54 (6): 763-8
13. Golazari GH, Dawson NV, Speroff T, et al. Prolonged QTc intervals on admission electrocardiograms: prevalence and correspondence with admission electrolyte abnormalities. Conn Med 2007; 71 (7): 389-97
14. Pasquier M, Pantet O, Hugli O, et al. Prevalence and determinants of QT interval prolongation in medical inpatients. Intern Med J. Epub 2011 Feb 8
15. Darpö B. Spectrum of drugs prolonging QT interval and the incidence of torsades de pointes. Eur Heart J Suppl 2001; 3 Suppl. K: K70-80
16. Hodges M. Rate correction of the QT interval. Card Electrophysiol Rev 1997; 1: 360-3 (Pubitemid 127503231)
17. Chiladakis J, Kalogeropoulos A, Arvanitis P, et al. Preferred QT correction formula for the assessment of drug-induced QT interval prolongation. J Cardiovasc Electrophysiol 2010; 21: 905-13
18. Drew BJ, Califf RM, Funk M, et al. Practice standards for electrocardiographic monitoring in hospital settings: an American Heart Association scientific statement from the Councils on Cardiovascular Nursing, Clinical Cardiology, and Cardiovascular Disease in the Young. Circulation 2004; 110 (17): 2721-46 (Pubitemid 39453025)